Abstract:Key PointsNitric oxide (NO) is a gaseous signalling molecule that is involved in the regulation of the cardiovascular, immune and nervous systems.In the CNS, NO is involved in many processes, including the regulation of synaptic plasticity, the sleep–wake cycle, neurosecretion, fluid balance and reproductive processes. In the PNS, NO is an inhibitory neurotransmitter that mediates the non-adrenergic, non-cholinergic relaxation of smooth muscle in both the gastrointestinal and urogenital tracts.NO exerts its effect on an array of functions through the activation of several intracellular signalling pathways. One key pathway is the soluble guanylyl cyclase–cyclic GMP–protein kinase G system.Physiological amounts of NO are neuroprotective, owing to S-nitrosylation of NMDA (N-methyl-D-aspartate) receptor subunits or of the active sites of caspases. Furthermore, NO activates Akt and CREB (cyclic AMP-responsive-element-binding protein), which are involved in two important survival pathways. NO also induces haem oxygenase 1, a key enzyme in the cellular stress response.If it is produced in excess, or if a cell is under conditions of oxidative stress, NO becomes noxious and may undergo an oxidative–reductive reaction to form toxic compounds known as reactive nitrogen species (RNS), which cause cell damage. Both NO and RNS have a pathogenetic role in the onset and development of neurodegenerative disorders.Although drugs that act on the NO–cGMP pathway are commonly used to treat impotence, lung diseases and pulmonary hypertension, their use for the prevention of neurodegenerative disorders is unlikely. The use of natural antioxidants, such as polyphenols, has been proposed for the prevention or treatment of Alzheimer's disease because of their in vitro ability to counteract NO-induced damage. However, the pharmacokinetics of these substances may limit their use in humans, and so more effort would be required to make these natural substances efficient in the treatment of neurodegenerative disorders.

[Progress in the Studies on Neuronal Nitric Oxide Synthase Inhibitors].

Progress in inhibitors of nitric oxide synthase

Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity

Nitric oxide in the cardio-cerebrovascular system: Source, regulation and application

Study on the Technology of Nitric Oxide (no) Detection in Vitro and in Vivo

Roles of Nitric Oxide Synthase Isoforms in Neurogenesis

nNOS and Neurological, Neuropsychiatric Disorders: A 20-Year Story

Research Progress of Inducible Nitric Oxide Synthase Inhibitors

Specificity of Inducible Nitric-Oxide Synthase Inhibitors: Prospects for Their Clinical Therapy.

Post-translational regulation of neuronal nitric oxide synthase: implications for sympathoexcitatory states

The dynamic detection of NO during stroke and reperfusion in vivo.

Nitric oxide-mediated pathways and its role in the degenerative diseases.

[Research progress in the regulation of endothelial nitric oxide synthase activity and cardiovascular diseases].

The role of neuronal nitric oxide synthase in the regulation of cardiac function

Inducible Nitric Oxide Synthase and Brain Hypoxic-Ischemic Brain Damage

Targeting nitrosative stress for neurovascular protection: new implications in brain diseases.

Nitrergic modulation of ion channel function in regulating neuronal excitability

The Roles of Nitric Oxide Synthase/Nitric Oxide Pathway in the Pathology of Vascular Dementia and Related Therapeutic Approaches

Nitric oxide synthase: Biochemistry and molecular biology

Dynamics of Nitric Oxide and Peroxynitrite During Global Brain Ischemia/Reperfusion in Rat Hippocampus: NO-sensor Measurement and Modeling Study

Nitric oxide synthase in hypoxic or ischemic brain injury.